Moreover, at these inflammatory sites, a notable percentage of EBNA2+ cells co-expresses the proliferation marker Ki67, indicating the presence of proliferating B cell blasts in the latency III/growth phase of the infection, and/or in the E phase of the viral lytic cycle, when EBNA2 is still expressed (abortive lytic cycle). The gene discussed is MKI67; the disease is infection.